The role of immunohistochemical adrenomedullin and Bcl-2 expression in development of type-1 endometrial adenocarcinoma-Reference-Cited by-同舟云学术

The role of immunohistochemical adrenomedullin and Bcl-2 expression in development of type-1 endometrial adenocarcinoma

Published:2016-05 Issue:5 Volume:212 Page:450-455
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Bozkurt Kemal Kürşat,Yalçın Yakup,Erdemoğlu Ebru,Tatar Burak,Erdemoğlu Evrim,Çerçi Sevim Süreyya,Çiriş İbrahim Metin,Başpınar Şirin,Uğuz Afife,Kapucuoğlu Nilgün

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference31 articles.

1. Adrenomedullin expression in the human endometrium;Laoag-Fernandez;Endocrine,2000

2. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma;Kitamura;Biochem. Biophys. Res. Commun.,1993

3. Adrenomedullin and tumour microenvironment;Larráyoz;J. Transl. Med.,2014

4. Adrenomedullin and cancer;Zudaire;Regul. Pept.,2003

5. The expression and regulation of adrenomedullin in the human endometrium: a candidate for endometrial repair;Maybin;Endocrinology,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families;Cancers;2023-03-09

2. A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer;Clinical Proteomics;2018-12

3. Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment;Acta Obstetricia et Gynecologica Scandinavica;2018-10-11

4. Immunoexpression of DNA fragmentation factor 40, DNA fragmentation factor 45, and B-cell lymphoma 2 protein in normal human endometrium and uterine myometrium depends on menstrual cycle phase and menopausal status;Archives of Medical Science;2018

5. BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia;Pathology & Oncology Research;2017-12-21